Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Bioactive Peptide Market – Market Insight
Bioactive peptides are amino acids combined together through a covalent bond. Bioactive peptides are extracted from various natural sources, thereby providing a variety of health benefits such as better cardiovascular, digestive, endocrine functioning, as well as the immune and nervous system. They are also used in protecting important contents of food and beverages, resulting in decreased oxidation and degradation of the products. Although these peptides are extracted from natural sources, some of them have been designed with the help of chemical synthesis.
Furthermore, bioactive peptides, as well as bioactive proteins are part of a balanced diet. The prominent factor driving the market demand is increasing incidence of chronic diseases, and growing geriatric population. Moreover, growing interest in bioactive peptides is driving the scientific community and the food industry to develop new food additives and functional products based on bioactive peptides.
The global bioactive peptide market size was valued at US$ 3,265.2 Mn in 2017, and is expected to exhibit a CAGR of 9.4% over the forecast period (2018–2026).
Figure 1. Global Bioactive Peptide Market Value (US$ Mn), by Region, 2018
Source: Coherent Market Insights Analysis (2019)
Increasing incidence of chronic diseases such as diabetes, cancer, cardiovascular disease, chronic obstructive pulmonary disease (COPD), and others is propelling the global bioactive peptide market growth.
Increasing incidence of diseases like diabetes, cancer, and respiratory disorders is expected to drive growth of the global bioactive peptide market. According to the International Federation of Diabetes, 2017 report, around 425 million adults were suffering from diabetes globally, and the number is expected to reach 629 million by 2045.
According to a press release on September 2018 by the International Agency for Research on Cancer, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. Moreover, 1 in 5 men, and 1 in 6 women worldwide develop cancer during their lifetime, and 1 in 8 men, and 1 in 11 women die from the disease.
According to World Health Organization, 2017 statistics, an estimated 3.17 million incidences of chronic obstructive pulmonary disease (COPD) were recorded in 2015, which is COPD accounted for 5% of deaths globally in 2015. More than 90% of COPD incidences occur in low and middle income countries.
Innovations and products launches by market players is expected to drive growth of the bioactive peptides market during the forecast period. In November 2018, Nuritas Ltd., announced the commercial launch of Peptide which contains anti-inflammatory bioactive peptides. It was the first bioactive ingredient discovered and delivered through artificial intelligence.
Figure 2. Global Bioactive peptide Market Share (%), by Therapeutic Area
Source: Coherent Market Insights Analysis (2019)
Growing Demand for nutritional supplements
There has been increasing awareness among the populace regarding disease conditions, owing to initiatives and campaigns by government organizations, and increasing healthcare spending by government organizations are projected to drive growth of the global bioactive peptide market. According to Council for Responsible Nutrition (CRN) Washington, October 2018, Consumer Survey on Dietary Supplements, conducted by Ipsos Public Affairs found that 75% of U.S. adults take dietary supplements in 2018, compared to 65% in 2009.
Furthermore, strategic collaborations between market players for development of innovative products is expected to facilitate demand for bioactive peptides. For instance, in December 2018, Nestle and Nuritas Ltd. collaborated to discover food derived bioactive peptides.
Key Players
Major players operating in the global bioactive peptides market include Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., and Valio Oy among others.
US :
INDIA :
UK :
JAPAN :
U.S. :
+1-206-701-6702
UK :
+44-020-8133-4027
JAPAN :
+81-50-5539-1737
INDIA :
+91-848-285-0837
Sales Office (U.S.) : 
